The complete guide to getting an ADHD diagnosis in the UK

Our guide to getting an ADHD diagnosis covers what the current pathways are, what they involve, what they cost, how long they take, and how to navigate them.

Guide · Updated 15 October 2026

Getting properly assessed for an ADHD diagnosis in the UK in 2026 is harder than it should be, takes longer than it should take, and costs more than most people can afford. The NHS pathway has waiting lists measured in years rather than months. The private pathway has costs that range from manageable to prohibitive. The Right to Choose pathway sits in between but is poorly understood, inconsistently implemented, and actively obstructed by some GP practices. The result is a system in which the people who need diagnosis most are often the people least able to navigate the obstacles required to access it.

This is not an accident of capacity. It is the predictable outcome of a system that was built around the assumption that ADHD is rare, that adult ADHD is rarer still, and that ADHD diagnosis demand could be met by a small specialist workforce operating at clinical scale. None of those assumptions has survived contact with the actual prevalence of ADHD in the UK adult population. The system has not adjusted. The backlog continues to grow. And the people seeking diagnosis are left to navigate an infrastructure that was not designed for them.

This guide to getting an ADHD diagnosis covers what the current ADHD diagnosis pathways actually are, what each one involves, what they cost, how long they take, and how to navigate the obstacles built into each. It covers the ADHD assessment itself — what happens, what to expect, what a competent assessment looks like, and what an incompetent one looks like. And it covers what happens after diagnosis — medication, support, coaching, and the work of integrating a diagnosis into the rest of a life.

Frequently asked questions about ADHD diagnosis in the UK

How do I get an ADHD diagnosis in the UK?

There are three routes to an ADHD diagnosis in the UK: the NHS pathway, the Right to Choose pathway, and the private pathway. The NHS pathway involves a GP referral to your local NHS ADHD assessment service, which continually means actually being on the second pathway due to local NHS-led ADHD care being materially non existent and the NHS more reliant on paying private-providers than ever. The Right to Choose pathway uses your legal right under the NHS Constitution to choose your provider, allowing you to be referred to an approved independent provider at NHS cost rather than waiting for the local NHS service. The private pathway involves paying for an assessment directly, with costs ranging from around £600 to £2,500 depending on the provider. All three routes lead to the same diagnosis if conducted properly, but the cost, waiting time, and accessibility differ substantially.

How long is the NHS ADHD waiting list?

NHS ADHD assessment waiting times vary significantly by integrated care board, but most are between eighteen months and four years for adults. Some areas of the UK have waiting lists that exceed eight years. The Royal College of Psychiatrists has described the situation as a national capacity failure. Waiting times for children are typically shorter than for adults but still measured in years rather than months in most areas. The Right to Choose pathway can substantially reduce waiting times by routing patients to approved independent providers with shorter queues.

Can I get an ADHD diagnosis privately?

Yes. Private ADHD assessments are widely available in the UK, with costs typically ranging from £600 to £2,500. The variation reflects differences in provider quality, assessment depth, and what is included — some providers include follow-up appointments, medication titration, and ongoing prescribing support in their cost; others charge separately for each. A private diagnosis from a qualified provider is clinically equivalent to an NHS diagnosis and materially the same outcome at the end of the assessment pathway. However, private providers vary substantially in quality, and the assessment process should follow NICE guidelines regardless of route. The Neurodiversity Directory maintains a verified listing of ADHD assessment providers.

What is Right to Choose for ADHD?

Right to Choose is a legal right under the NHS Constitution that allows patients in England to choose any approved provider for their NHS care, including ADHD assessment. This means you can request a referral to an independent provider that holds an NHS contract, and the assessment will be funded by the NHS rather than paid for privately. The Right to Choose pathway typically has substantially shorter waiting times than direct NHS services. The process requires your GP to write the referral, which some GPs refuse or do not understand. Right to Choose applies in England only; Scotland, Wales, and Northern Ireland have different arrangements.

How much does a private ADHD assessment cost in the UK?

Private ADHD assessments in the UK typically cost between £600 and £2,500. The lower end usually includes the assessment itself and a written report. The middle range often includes follow-up appointments and medication titration if relevant. The upper end typically includes ongoing prescribing support, regular reviews, and continuity of care. Cost alone is not a reliable quality indicator — some excellent providers charge moderate fees, and some expensive providers conduct rushed or superficial assessments. The factors that matter are the assessor’s qualifications, the depth and structure of the assessment, and whether the process follows NICE guidelines.

Can a GP diagnose ADHD?

No. Under UK guidelines, ADHD diagnosis must be made by a specialist — typically a psychiatrist, specialist nurse, or paediatrician with relevant training. GPs can refer patients for assessment, prescribe medication once diagnosed (under shared care arrangements), and provide ongoing primary care. They cannot conduct the diagnostic assessment itself. Some GPs are more knowledgeable about ADHD pathways than others, and the quality of GP-level support varies substantially across the UK. Stigma and misinformation is also known to go hand in hand with GPs and ADHD care, which speaks to how unqualified and misled general practitioners are on neurodivergent conditions in 2026.

What does an ADHD assessment involve?

A competent adult ADHD assessment typically involves a structured clinical interview lasting between 90 minutes and three hours, completion of validated questionnaires (often including the DIVA, ASRS, or similar instruments), input from someone who knew you as a child where possible, a developmental history, and consideration of differential diagnoses to rule out other explanations for the symptoms. The assessor will look for evidence of ADHD symptoms in childhood as well as adulthood, since adult-onset ADHD is not recognised in current diagnostic criteria. The assessment results in a written report confirming or excluding diagnosis, and where confirmed, recommendations for treatment and support.

What happens after an ADHD diagnosis?

After diagnosis, the immediate clinical questions are whether to pursue medication, what support to put in place, and how to integrate the diagnosis into the rest of life. Medication options include stimulants (methylphenidate, lisdexamfetamine, dexamfetamine) and non-stimulants (atomoxetine, guanfacine), titrated to the individual under specialist supervision. Non-medical support can include neurodivergent coaching, cognitive behavioural therapy or metacognitive therapy (adapted for ADHD), workplace adjustments, and access to peer communities. The diagnostic process often produces significant emotional response — relief, grief for years lived without understanding, reframing of past difficulties — and this aspect of post-diagnostic life is frequently underprepared for by the assessment process itself.

Do I need an ADHD diagnosis to get support?

For some forms of support, yes; for others, no. Medication requires a formal diagnosis. Workplace adjustments under the Equality Act 2010 require evidence of a disability, which formal diagnosis provides most reliably but is not the only route. Access to Work funding generally requires diagnosis. Coaching, peer support, self-directed adjustments, and access to community resources do not require formal diagnosis. Many adults discover ADHD-aware ways of working that substantially improve their lives without ever pursuing formal assessment, particularly when waiting times or costs make assessment unrealistic.

Is it worth getting an ADHD diagnosis as an adult?

For most adults who seek diagnosis, yes — but the value comes from different things for different people. For some, the value is access to medication, which can substantially change functioning. For others, the value is the reframing — understanding that a lifetime of struggle was not personal failure but unrecognised neurology. For others, the value is access to workplace protections, support, and community. For some adults, the value is primarily emotional and explanatory rather than functional. The decision to seek diagnosis is individual, and the costs (time, money, emotional difficulty of the assessment process) are real. But for adults who have spent decades not understanding why ordinary tasks were unreasonably hard, the diagnostic process is often the start of being able to design a life that works.

Why getting an ADHD diagnosis in the UK is harder than it should be

The UK ADHD assessment system was built around prevalence assumptions that have not been true for at least a decade. NHS service capacity was set on the basis that ADHD was a rare childhood condition that mostly resolved by adulthood, and that adult ADHD assessment demand would be modest and specialist. Neither assumption has survived contact with the actual prevalence of ADHD in the UK adult population, which is now estimated at three to four per cent — meaning approximately two million adults, of whom the substantial majority are undiagnosed. The system was built for a small fraction of the population that turned up. It has not been rebuilt to meet the demand it now faces.

The capacity gap has multiple compounding effects. Local NHS waiting lists have grown to between eighteen months and several years in most areas, with some integrated care boards reporting waits in excess of eight years. The system’s response to growing demand has not been to expand capacity meaningfully but to introduce gatekeeping measures — referral criteria that exclude patients who do not meet narrow thresholds, second-tier triage processes that add months to the pathway, and quiet rationing through restrictive shared care agreements that limit ongoing prescribing once diagnosed.

The Right to Choose pathway exists as a legal workaround to the local NHS backlog, but it is poorly implemented. Many GPs do not know it exists. Some refuse to make Right to Choose referrals on principle, citing concerns about cost-shifting to integrated care budgets or because of stigma they hold, misinformed, of the “epidemic” of increases in ADHD and the landscape of private providers assessing anyone who requests a diagnosis (even though that IS the Right to Choose system the NHS created). Others write the referrals but then refuse to enter shared care arrangements with the chosen provider, leaving the patient with a diagnosis but no route to NHS-funded medication. The pathway works when it works, but the consistency of access varies dramatically by GP, by region, and by the patient’s capacity to push back against gatekeeping.

The private pathway is the most reliable in terms of speed, but it transfers the cost of system failure onto the individual. A private assessment costs between £600 and £2,500. Medication titration adds further costs. Ongoing private prescribing, where shared care has not been agreed, can run to hundreds of pounds per month indefinitely. For adults whose ADHD is itself a barrier to financial stability, the private pathway is structurally inaccessible. The system that fails them on the NHS expects them to pay their way out of the failure.

This is the wider pattern within which any individual diagnosis decision is being made. The pathway choices below are practical tools for navigating a broken system, not endorsements of how the system should work. The Directory’s editorial position on this is unchanged from the wider coherence-first frame: the diagnosis backlog is structural infrastructure failure, not individual misfortune, and the work of fixing it sits with the institutions that built it.

What ADHD actually is, and why diagnosis matters

ADHD is a difference in how the brain regulates attention, executive function, and motivation. The clinical diagnostic criteria describe symptoms — inattention, hyperactivity, impulsivity — but the underlying mechanisms are better understood as a difference in the dopamine and norepinephrine signalling systems that govern motivation, reward, and sustained attention. The ADHD brain is not broken nor deficient; it operates on different signalling parameters, which produces the observable patterns clinicians recognise as ADHD.

The practical consequence is that ADHD brains struggle with tasks that require sustained engagement without intrinsic interest, and excel at tasks that capture attention through novelty, urgency, or genuine interest. This is not inconsistency. It is the predictable behaviour of a nervous system that needs stronger dopamine signal to maintain engagement than the not-real “neurotypical baseline” provides. What looks from the outside like inability to focus is more accurately understood as a filtering system that cannot sustain suppression of competing inputs without sufficient dopaminergic support.

This matters for the diagnosis question because it explains why so many adults arrive at the diagnostic process having spent decades being told they were lazy, careless, or insufficiently motivated. The framing is wrong. The behaviour was the predictable output of a nervous system operating without the support it needed. Diagnosis is the point at which the framing changes — from personal failure to recognisable neurology — and that change of framing is often the most significant outcome of the diagnostic process, regardless of whether medication follows.

The recent research literature has been moving toward reconceptualising ADHD in ways that the diagnostic system has not yet caught up with. The proposal to rename ADHD as Energy Deficit Hyperactivity Disorder reflects a growing recognition that the central feature is not attention deficit but energy regulation difficulty — the brain runs through its regulatory capacity faster than the neurotypical baseline, producing the apparent attention problems as a downstream effect of energy depletion. The reframing of ADHD as a circadian rhythm disorder operates on a related axis, recognising that the dysregulation extends beyond attention into sleep, mood, and metabolic regulation. The current diagnostic process has not absorbed these reframings, but they inform how the more sophisticated assessors are thinking about what they are diagnosing.

Diagnosis matters for three distinct reasons, and the relative weight of each varies by individual. The first is access to medication, which for many adults substantially changes daily functioning by providing the dopaminergic support the brain has been operating without. The second is access to legal protections and adjustments — under the Equality Act 2010, ADHD diagnosis provides documentation that supports workplace adjustments, educational accommodations, and Access to Work funding. The third is the reframing of identity and personal history — the recognition that decades of difficulty were not character failure but unrecognised neurology, which for many adults is the most significant outcome of the entire diagnostic process.

For some adults, only one of these reasons matters. For others, all three matter substantially. The decision to pursue diagnosis is shaped by which combination applies to the individual life, the cost-benefit of each pathway available, and the realistic alternative if diagnosis is not pursued.

The NHS pathway: how it works, and how long it takes

The NHS ADHD diagnosis pathway begins with a GP appointment. The patient describes the symptoms and history that bring them to suspect ADHD, the GP makes a clinical judgement about whether to refer, and if the referral is made, the patient enters the queue at their local NHS ADHD assessment service. In practice, each of these steps contains friction that the pathway documentation does not acknowledge.

The GP appointment varies in quality dramatically. Some GPs are well-informed about ADHD, take adult presentation seriously, and refer without obstruction. Others are sceptical of adult ADHD as a category, dismiss self-reported symptoms, suggest the patient is misattributing normal life difficulty, or refuse to refer at all. The patient’s capacity to advocate for themselves at this stage substantially affects whether they get into the system. A patient who arrives with a clear written history, examples of childhood symptoms, family corroboration if available, and the language of established ADHD presentation is more likely to be referred than a patient who describes symptoms in vague terms and trusts the GP to interpret them correctly.

Once referred, the patient enters the local NHS ADHD service queue. Waiting times are now measured in years across most of England. The Royal College of Psychiatrists’ own reporting acknowledges that current waiting times exceed clinical reasonableness in most areas. Specific waiting times by integrated care board are published variably and often inaccurately — the publicly stated wait is sometimes shorter than the actual wait by a substantial margin, because the publicly stated wait excludes the triage queue, the pre-assessment screening queue, or other queues that the patient has to pass through before reaching the main waiting list.

During the wait, patients receive limited or no support. Some services send periodic communication confirming the patient is still on the list. Others go silent for years at a time. Crisis-level support during the wait is sometimes available but is generally inadequate to the actual need. For patients whose lives are deteriorating during the wait — losing jobs, relationships, housing, financial stability — the system does not provide meaningful intervention.

When the assessment finally takes place, it is usually a single appointment of one to three hours with a specialist (psychiatrist, specialist nurse, or specialist psychologist depending on the service). The assessor reviews history, conducts a structured interview, scores validated questionnaires, and reaches a diagnostic decision. The written report is typically issued within a few weeks. If diagnosis is confirmed and medication is indicated, the patient enters a titration process — usually conducted under specialist supervision over several months — during which the medication and dose are adjusted to find the optimal regime.

After titration, the patient is usually transferred to GP-led shared care for ongoing prescribing. Shared care arrangements vary significantly. Some GP practices accept them readily and provide effective ongoing care. Others refuse shared care, meaning the patient must continue with specialist follow-up indefinitely (which the NHS service often cannot sustain) or pay for private prescribing. The shared care gap is one of the points at which the NHS pathway most frequently fails patients post-diagnosis.

The NHS pathway, when it works, produces a clinically equivalent outcome to the other pathways. The diagnosis is recognised, the medication is funded, the ongoing prescribing is integrated with the patient’s other healthcare. The cost to the patient is time and persistence. For patients who can wait, can self-advocate effectively at each gatekeeping point, and can sustain themselves during the multi-year wait, the NHS pathway is the lowest-cost route to diagnosis. For patients who cannot — because their lives are deteriorating faster than the wait allows for, or because they lack the advocacy capacity to push through the obstacles — the NHS pathway is not realistically available.

The Right to Choose pathway: the route most people don’t know exists

Right to Choose is a legal right under the NHS Constitution. Patients in England are entitled to choose any approved NHS provider for their care, including ADHD assessment. In practice, this means a patient whose local NHS service has a multi-year waiting list can choose to be referred to an approved independent provider with a shorter wait, and the assessment is funded by the NHS at no cost to the patient.

The pathway works as follows. The patient researches Right to Choose providers (several exist, with varying specialisms and waiting times — the Directory’s listings cover the established options). The patient identifies a provider whose service matches their needs and whose current waiting time is acceptable. The patient requests a Right to Choose referral from their GP, providing the GP with the provider details and the relevant NHS England guidance on Right to Choose if needed. The GP writes the referral. The patient is assessed by the chosen provider, with the assessment funded through Right to Choose at NHS cost. If diagnosis is confirmed and medication is indicated, the chosen provider conducts titration and then transfers the patient to GP-led shared care.

The pathway is straightforward in design and frequently obstructed in practice. The most common obstructions are GPs who refuse to make the referral, GPs who claim not to understand the Right to Choose process and direct the patient back to the standard NHS pathway, and integrated care boards that have informally pressured local GPs to limit Right to Choose referrals on cost-control grounds. None of these obstructions is lawful. Right to Choose is a patient right enshrined in the NHS Constitution, not a discretionary GP decision. But the gap between the legal position and the operational reality is wide, and many patients are turned away from Right to Choose referrals despite being legally entitled to them.

Patients who encounter GP refusal have several options. The first is to ask the GP to document the refusal in writing — many GPs will retract a verbal refusal when asked to put it in writing, because the refusal is not defensible against the NHS guidance. The second is to escalate to the practice manager, who is often better informed about Right to Choose than individual GPs. The third is to change GP practices, since Right to Choose entitlement is a national right and not subject to local practice policy. The fourth is to submit a formal complaint to the integrated care board, which is required to respond and which is generally aware that systematic Right to Choose refusals are not legally defensible.

The shared care problem is the second major obstruction. After Right to Choose assessment and titration, the patient needs to be transferred to GP-led shared care for ongoing prescribing. Some GP practices refuse to enter shared care with Right to Choose providers specifically, citing concerns about the quality of the prescribing protocols (concerns that are generally not evidence-based and that do not apply to direct NHS assessments). This leaves the patient with a confirmed diagnosis but no NHS-funded route to ongoing medication. The options at this point are to fund private prescribing indefinitely, to switch GP practices to one that will accept shared care, or to push back through formal complaints. The Directory’s editorial position is that systematic shared care refusal for Right to Choose patients is itself a Right to Choose violation, but the legal position on this is not yet settled.

The full mechanics of Right to Choose — how to identify approved providers, how to phrase the request to a GP, how to handle refusal, how to navigate the shared care question — are covered in detail in our dedicated Right to Choose guide. This section provides the orientation; the full pathway covers the navigation.

For most adults seeking ADHD diagnosis in 2026, Right to Choose is the route that combines the lowest financial cost with the shortest realistic timeline. The NHS pathway is free but takes years. The private pathway is fast but expensive. Right to Choose is free and faster than the NHS pathway, with the caveat that the navigation requires active patient engagement and willingness to push back against gatekeeping.

The private pathway: what it costs, and what to look for

Private ADHD assessment in the UK is widely available, with costs ranging from around £600 at the entry level to £2,500 or more at the higher end. The cost variation reflects differences in the depth of assessment, the qualifications of the assessor, what is included in the price, and the brand positioning of the provider. Cost alone is not a reliable quality indicator. Some excellent providers charge moderate fees because their model is built around accessibility. Some expensive providers conduct rushed or superficial assessments because their model is built around volume at premium price points.

The factors that matter when choosing a private provider are predictable. The assessor’s qualifications are the first filter. ADHD assessment should be conducted by a psychiatrist, specialist nurse with relevant training, or specialist psychologist with relevant qualifications and supervision. Assessments conducted by practitioners without these qualifications are not clinically valid and may not be accepted by GPs for ongoing shared care or by employers for adjustment purposes.

The structure of the assessment is the second filter. A competent adult ADHD assessment takes between 90 minutes and three hours, includes a structured clinical interview using a validated instrument such as the DIVA, considers childhood as well as adult symptoms, considers differential diagnoses, and produces a written report that documents the reasoning behind the diagnostic conclusion. Assessments that take 30 minutes, use questionnaires without clinical interview, or skip the developmental history are not following NICE guidelines and should be avoided regardless of cost.

What is included in the fee is the third filter. Some providers include only the assessment and report. Others include follow-up appointments, medication titration, and a period of ongoing prescribing. Others include comprehensive long-term care. The headline price does not tell you which model you are buying, and patients often find that the assessment cost is the start of a much larger ongoing cost rather than the total.

The provider’s approach to shared care is the fourth filter. Some private providers will support the patient’s transition to GP-led shared care actively, providing the documentation and prescribing protocols GPs need. Others leave shared care entirely to the patient to negotiate, which often means it does not happen and the patient remains in private prescribing indefinitely. For patients who can sustain private prescribing costs indefinitely, this is not a problem. For patients who cannot, the provider’s shared care support is a major factor in the long-term cost of the diagnosis.

The provider’s broader practice model is the fifth filter. Some private ADHD providers operate at very high volume, with assessments slotted into 30-minute appointments and minimal continuity of care. Others operate at lower volume with longer assessments and ongoing clinical relationships. The high-volume model is faster and often cheaper but produces lower-quality assessment and follow-up. The low-volume model is slower and more expensive but produces higher-quality outcomes. The right model depends on what the patient needs from the diagnosis.

For most adults pursuing private diagnosis, the practical strategy is to identify two or three providers whose qualifications, structure, and approach match their needs, compare costs and waiting times, and choose the best fit. The Directory’s verified listings cover the established UK private ADHD assessment providers, with manual verification of qualifications, no paid placements, and information on which providers support Right to Choose referrals as an alternative to direct private payment.

What happens during an ADHD assessment

A competent ADHD assessment, regardless of pathway, follows a structured process. Understanding what to expect makes the assessment itself less stressful and helps the patient prepare in ways that improve the quality of the assessment.

The assessment begins with developmental history. The assessor will ask about childhood — what school was like, what behaviour was like, what concerns parents or teachers raised, what the patient’s experience of childhood attention, energy, and emotional regulation was. The diagnostic criteria require evidence of ADHD symptoms in childhood, even when the diagnosis is being made in adulthood. Patients who can bring documentation — school reports, family memories, photographs of childhood school books with characteristic handwriting and patterns — give the assessor stronger evidence to work with than patients who rely on memory alone.

The assessment then moves to adult presentation. The assessor will work through a structured interview, often using the DIVA instrument or equivalent, covering each of the diagnostic criteria across both inattention and hyperactivity/impulsivity domains. For each criterion, the assessor will ask for specific examples — what the patient experiences, what others observe, how it affects daily life. The interview is detailed and can take 90 minutes or longer. Patients who arrive prepared with examples for each criterion area have a more efficient assessment than patients who try to generate examples on the spot.

The assessment includes consideration of differential diagnoses. ADHD symptoms can overlap with anxiety disorders, depression, trauma responses, sleep disorders, thyroid conditions, and other presentations. A competent assessor will explicitly consider these alternatives and rule them in or out, often referring back to the patient’s medical history to do so. Patients who arrive with a clear understanding of their broader mental and physical health context help the assessor reach a clearer diagnostic conclusion.

Where possible, the assessment includes input from someone who knew the patient as a child — usually a parent, but sometimes an older sibling or other family member. This is not always possible, particularly for adults whose parents are deceased or estranged, and competent assessors will work with the available evidence rather than excluding the patient. But where childhood corroboration is available, the diagnosis is generally stronger and more confidently delivered.

The written report follows the assessment, usually within two to four weeks. The report documents the assessor’s reasoning, the evidence considered, the diagnostic conclusion, and the recommendations. A high-quality report covers ADHD presentation, considers co-occurring conditions (autism, dyslexia, dyspraxia, anxiety, depression — many adults with ADHD have one or more co-occurring conditions), and provides specific recommendations for medication, support, and adjustments. A low-quality report consists of a few paragraphs confirming or excluding diagnosis without detailed reasoning.

Patients should ask in advance what the report will include and request a more detailed report if the standard offering is thin. The report is the documentation that supports workplace adjustments under the Equality Act 2010, Access to Work funding applications, and ongoing clinical care. A weak report makes all of these harder.

The emotional experience of the assessment itself is often substantial. Many adults arrive at the assessment having spent decades not understanding why ordinary life was unreasonably hard. The structured interview process — being asked detailed questions about your experience and being taken seriously — is for many adults the first time anyone has engaged with their internal experience at that level of detail. The diagnosis itself, when confirmed, often produces a complex emotional response combining relief, grief, anger, and reframing. The strongest providers anticipate this and provide follow-up support; the weakest deliver the diagnosis and disappear.

What happens after an ADHD diagnosis

Diagnosis is the start of the work, not the end. The clinical questions following diagnosis are about treatment options, support structures, and the practical integration of the diagnosis into the rest of life. The emotional and identity-level questions are about what the diagnosis means for the patient’s understanding of their own life and history.

The medication question is usually the most immediate. ADHD medication falls into two categories: stimulants and non-stimulants. Stimulants — methylphenidate (Ritalin, Concerta, Equasym), lisdexamfetamine (Elvanse), and dexamfetamine — are first-line treatment for most adults with ADHD and produce significant benefit for the majority of those who try them. Non-stimulants — atomoxetine (Strattera), guanfacine, and others — are alternatives for patients who cannot tolerate stimulants or for whom stimulants are clinically contraindicated. Medication is titrated under specialist supervision, usually over several months, to find the optimal type and dose for the individual.

Medication is not the only treatment option, but for most adults whose ADHD significantly affects daily functioning, it is the most clinically effective intervention available. The decision to try medication is individual, and some adults choose not to pursue it for reasons that range from clinical (other health conditions that make it inadvisable) to personal (preference for non-pharmacological approaches). The decision should be informed by accurate information about what medication does and does not do, rather than by stigma or misinformation about stimulant medication generally.

Non-medical support takes several forms. Neurodivergent coaching is one of the most established post-diagnostic support options, with coaches working with clients on the practical integration of ADHD-aware ways of working — structuring time, managing energy, building external systems to support executive function, navigating relationships and workplaces with ADHD-informed strategies. The Directory’s coaching listing category covers the established UK neurodivergent coaches, with verification of qualifications and approach. Coaching is typically not NHS-funded and is paid for privately or through Access to Work, but it is one of the higher-value post-diagnostic investments for many adults.

Cognitive behavioural therapy adapted for ADHD is another evidence-based option, available through some NHS services and through private providers of neurodivergent counselling and therapy. It is distinct from generic CBT and works with the specific patterns of ADHD presentation rather than treating ADHD as if it were anxiety or depression. Peer support — through ADHD-specific groups, online communities, or informal connections with other diagnosed adults — is often described as one of the most significant ongoing supports, particularly for the reframing and identity work that diagnosis triggers.

Workplace adjustments under the Equality Act 2010 are available to any employee with a diagnosed disability, and ADHD diagnosis provides the documentation that supports adjustment requests. The specific adjustments that work for ADHD vary by individual and role but typically include flexibility around working hours, reduction of distracting environmental factors, support with documentation and administrative tasks, and clear written communication of expectations. The dedicated workplace guides cover this in more detail.

Access to Work is a UK government scheme that funds workplace support for disabled employees, including ADHD-related support. Funding can cover coaching, assistive technology, ergonomic equipment, and other adjustments. The Access to Work application process is administratively heavy and our dedicated Access to Work guide covers it in detail, but for adults whose ADHD affects their working capacity, it is a substantial source of funded support that many do not realise is available to them.

The emotional and identity work that follows diagnosis is often the most significant and the least clinically supported part of the process. Many adults experience grief for the life that might have been lived if diagnosis had come earlier, anger at the systems and people who failed to recognise their ADHD across decades, and a complex reframing of past relationships and experiences in light of the new understanding. This work is rarely time-limited. The integration of the diagnosis into a stable identity often takes years rather than months. Coaching, therapy, peer support, and accurate information about the ADHD experience all support this work, but it is fundamentally an individual process of making sense of a life in new terms.

For most adults, the diagnosis itself is the start of a longer process of building a life that works with ADHD rather than against it. The medication, support, and adjustments are tools in that work, not the work itself. The work is the longer-term project of designing daily life, work, relationships, and self-understanding around the reality of how the ADHD brain actually operates, rather than against the framework of how it does not.

News and updates.

Straight to your inbox.